Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms
0.320 Therapeutic group CTD_human Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. 19140230 2009
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms
0.320 Biomarker group CTD_human Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. 19140230 2009
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms
0.320 GeneticVariation group LHGDN Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese. 17763950 2008
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms
0.320 Biomarker group CTD_human Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection. 15492468 2004
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms
0.320 Therapeutic group CTD_human Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection. 15492468 2004
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms
0.320 AlteredExpression group LHGDN (4) COX-2, PPARgamma, Bcl-2, and survivin were overexpressed in gastric tumor, but the inhibition of COX-2 activity by Vioxx resulted in a significant reduction in serum and tumor levels of progastrin and gastrin and serum IL-8 and TNF-alpha levels, suggesting that gastrin and proinflammatory cytokines could mediate the up-regulation of COX-2 in gastric cancerogenesis. 14627349 2003